Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: A phase 1b, randomised, double-blind, placebo-controlled clinical trial
Hannah Kibuuka, Nina M. Berkowitz, Monica Millard, Mary E. Enama, Allan Tindikahwa, Arthur B. Sekiziyivu, Pamela Costner, Sandra Sitar, Deline Glover, Zonghui Hu, Gyan Joshi, Daphne Stanley, Meghan Kunchai, Leigh Anne Eller, Robert T. Bailer, Richard A. Koup, Gary J. Nabel, John R. Mascola, Nancy J. Sullivan, Barney S. GrahamMario Roederer, Nelson L. Michael, Merlin L. Robb, Julie E. Ledgerwood*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
111Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: A phase 1b, randomised, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.